Author`s Reply
Comment on
-
How to improve the management of a patient with heparin-induced thrombocytopenia?Anatol J Cardiol. 2019 Nov;22(6):339. doi: 10.14744/AnatolJCardiol.2019.28455. Anatol J Cardiol. 2019. PMID: 31789608 Free PMC article. No abstract available.
References
-
- Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033–69. - PubMed
-
- Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Eur Heart J. 2019:ehz405. [Epub ahead of print] - PubMed
-
- Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin induced thrombocytopenia:a propensity score matched study. Blood. 2015;125:924–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources